Buying The Medtronic Turnaround Story

Feb. 02, 2023 9:52 PM ETMedtronic plc (MDT) StockMDT20 Comments

Summary

  • Medtronic is working through top-line headwinds.
  • The company actually stands to benefit from incremental top-line and EPS growth over the long term.
  • At 13x FY25 earnings and a 3.3% dividend yield, this price appears to be a good entry point.

Medtronic office in Pointe-Claire, QC, Canada.

JHVEPhoto

Medtronic (NYSE:MDT) is a developer and manufacturer of medical devices for cardiac, neuroscience, surgery, and diabetes. MDT has revenue exposure diversified across countries and has maintained its R&D budgets equal to or higher than its revenue growth. In other words, MDT prioritizes product

If you enjoyed this article and want more direct access to my research and ideas as well as the chance to chat with me and review my two model portfolios (dividend and long-only total return stocks) and my overall investing strategy, please note that my Marketplace Service called Equanimity Research is now live. I am very excited to foster a community of like-minded investors. You can now sign up for a two-week free trial* and there is a considerable discount for early annual subscribers.

*Free trial only valid for first-time subscribers.

This article was written by

Equanimity Investing helps you focus on protecting your principal and thinking long-term with your investments. I'm long treasuries, select high-quality companies, and will never use margin. As a generalist, I cover multiple sectors with a dividend and non-dividend long-only stock strategy over a 5-10+ year investment horizon. I also cover macroeconomics regarding monetary policy and excessive debt levels globally.All articles/blogs are for informational and entertainment purposes only. Under no circumstances should any of these articles/blogs or any published information be interpreted as investment advice, or as an offer to buy/sell any financial security. Perform your own due diligence. I welcome comments and corrections of all kinds.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of MDT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About MDT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MDT

Related Stocks

SymbolLast Price% Chg
MDT
--